Page 3 - Project Nextgen News Today

New report provides an in-depth review of the 10 drugs selected for the first cycle of Medicare drug price negotiations under President Biden’s IRA.

Growing evidence suggests that vaccines delivered by nasal spray or inhaler would block infections.

Lower drug copays for Medicare enrollees, price concessions for new COVID treatments spotlighted

Operator: Good afternoon, and welcome everyone to the GeoVax Third Quarter 2023 Corporate Update Call. My name is Mandeep and I will facilitate todays call.

OCGN earnings call for the period ending September 30, 2023.

A team of University of Maryland researchers developed a nasal spray vaccine that delivers the SARS-CoV-2 spike protein into cells of the airway in mice and hamsters, triggering an immune response that significantly reduced infection and spread of COVID-19.

OPK earnings call for the period ending September 30, 2023.

Operator: Hello, and welcome to Vir Biotechnologys Third Quarter 2023 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.

– Company to present new data at AASLD from Phase 2 chronic hepatitis B and chronic hepatitis delta clinical trials –– Company expanding strategic focus to autoimmune diseases and immuno-oncology –– Jennifer Towne, Ph.D., appointed as Executive Vice President and Chief Scientific Officer, effective November 6, 2023...

02.11.2023 - Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the third quarter ended September 30, 2023. “We continue to execute on our multiple clinical stage programs and look forward to sharing Phase ...